ARQT
Arcutis Biotherapeutics Inc
NASDAQ: ARQT · HEALTHCARE · BIOTECHNOLOGY
$22.37
-3.95% today
Updated 2026-04-29
Market cap
$2.91B
P/E ratio
—
P/S ratio
7.75x
EPS (TTM)
$-0.13
Dividend yield
—
52W range
$12 – $32
Volume
1.3M
Arcutis Biotherapeutics Inc (ARQT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.77M | $-14.09M | $-42.84M | $-113.03M | $-174.63M | $-257.71M | $-247.06M | $-112.16M | $-5.63M |
| Capital expenditures | $295000.00 | $295000.00 | $295000.00 | $321000.00 | $995000.00 | $23.28M | $428000.00 | $143000.00 | $686000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $27000.00 | $151000.00 | $824000.00 | $7.94M | $23.89M | $32.68M | $38.81M | $41.73M | $40.36M |
| Free cash flow | $-4.07M | $-14.38M | $-43.13M | $-113.35M | $-175.62M | $-281.00M | $-247.49M | $-112.30M | $-6.31M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | $72.35M | $122.81M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $3.29M | $31.37M | — | — | — | — |